secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2022-06-17T23:59:59+00:00
Accession:  0001193125-22-176473
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pliant shareholders re-elect directors, approve say-on-pay at 2022 annual meeting
--------------------------------------------------------------------------------

- Shareholders elected John Curnutte (22.7M for) and Smital Shah (22.7M for) as Class II directors.
- Advisory vote on named executive officer compensation passed with 27.9M for, 111.6K against.
- Advisory vote on frequency of future say-on-pay approved with 28.0M favoring one-year interval.
- Ratification of Deloitte & Touche as independent auditor for FY2022 approved with 34.1M for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000119312522176473/0001193125-22-176473-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000119312522176473/d370205d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-176473

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer